KYMR•benzinga•
Credit Suisse Initiates Coverage On Kymera Therapeutics with Outperform Rating, Announces Price Target of $63
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2022 by benzinga